BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15778056)

  • 1. Prediction of oral drug absorption in humans by theoretical passive absorption model.
    Obata K; Sugano K; Saitoh R; Higashida A; Nabuchi Y; Machida M; Aso Y
    Int J Pharm; 2005 Apr; 293(1-2):183-92. PubMed ID: 15778056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of effective intestinal membrane permeability considering bile micelle solubilisation.
    Sugano K
    Int J Pharm; 2009 Feb; 368(1-2):116-22. PubMed ID: 18992315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of oral absorption in humans by experimental immobilized artificial membrane chromatography indices and physicochemical descriptors.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2008 Aug; 360(1-2):96-106. PubMed ID: 18524510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ artificial membrane permeation assay under hydrodynamic control: correlation between drug in vitro permeability and fraction absorbed in humans.
    Velický M; Tam KY; Dryfe RA
    Eur J Pharm Sci; 2011 Oct; 44(3):299-309. PubMed ID: 21864679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new in vitro system for evaluation of passive intestinal drug absorption: establishment of a double artificial membrane permeation assay.
    Kataoka M; Tsuneishi S; Maeda Y; Masaoka Y; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2014 Nov; 88(3):840-6. PubMed ID: 25304077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug permeation through biomembranes: cyclodextrins and the unstirred water layer.
    Loftsson T
    Pharmazie; 2012 May; 67(5):363-70. PubMed ID: 22764564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational prediction of oral drug absorption based on absorption rate constants in humans.
    Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M
    J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADME evaluation in drug discovery. 7. Prediction of oral absorption by correlation and classification.
    Hou T; Wang J; Zhang W; Xu X
    J Chem Inf Model; 2007; 47(1):208-18. PubMed ID: 17238266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
    Winiwarter S; Bonham NM; Ax F; Hallberg A; Lennernäs H; Karlén A
    J Med Chem; 1998 Dec; 41(25):4939-49. PubMed ID: 9836611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A physiological model for the estimation of the fraction dose absorbed in humans.
    Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
    J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.
    Sugano K
    Int J Pharm; 2010 Mar; 387(1-2):103-9. PubMed ID: 20006692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug absorption based on immobilized artificial membrane (IAM) chromatography separation and calculated molecular descriptors.
    Yen TE; Agatonovic-Kustrin S; Evans AM; Nation RL; Ryand J
    J Pharm Biomed Anal; 2005 Jul; 38(3):472-8. PubMed ID: 15890485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of food effect by bile micelles on oral drug absorption considering free fraction in intestinal fluid.
    Sugano K; Kataoka M; Mathews Cda C; Yamashita S
    Eur J Pharm Sci; 2010 May; 40(2):118-24. PubMed ID: 20307655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
    Kotecha J; Shah S; Rathod I; Subbaiah G
    Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.